We are live on ! Find out more
SGI

Summit Global Investments Portfolio holdings

AUM $1.83B
1-Year Est. Return 22.56%
This Fund
S&P 500
This Quarter Est. Return
+9.39%
1 Year Est. Return
+22.56%
3 Year Est. Return
+60.44%
5 Year Est. Return
+82.72%
10 Year Est. Return
–
AUM
$1.56B
AUM Growth
+$224M
Cap. Flow
+$107M
Cap. Flow %
6.86%
Top 10 Hldgs %
23.64%
Holding
660
New
197
Increased
199
Reduced
106
Closed
124

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18.5M
2
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
3
MTUM icon
iShares MSCI USA Momentum Factor ETF
MTUM
+$9.92M
4
HSY icon
Hershey
HSY
+$8.28M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$8.11M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$11.9M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$11.4M
3
INCY icon
Incyte
INCY
+$9.85M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$8.36M
5
BBY icon
Best Buy
BBY
+$8.26M

Sector Composition

Rank Sector Weight
1 Technology 18.73%
2 Healthcare 12.12%
3 Financials 9.32%
4 Consumer Staples 9.11%
5 Consumer Discretionary 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VIG icon
176
Vanguard Dividend Appreciation ETF
VIG
$114B
$1.46M 0.09%
8,479
-274
-3% -$45.2K
T icon
177
AT&T
T
$163B
$1.45M 0.09%
77,837
+956
+1% +$17.9K
CPK icon
178
Chesapeake Utilities
CPK
$3.21B
$1.44M 0.09%
9,900
-100
-1% -$13.3K
NBIS
179
Nebius Group N.V.
NBIS
$47.7B
$1.44M 0.09%
23,837
+5,880
+33% +$433K
MPC icon
180
Marathon Petroleum
MPC
$83.7B
$1.44M 0.09%
+22,470
New +$1.44M
SWKS icon
181
Skyworks Solutions
SWKS
$10.6B
$1.44M 0.09%
9,271
+59
+0.6% +$9.44K
CVS icon
182
CVS Health
CVS
$122B
$1.44M 0.09%
13,917
+751
+6% +$69.4K
GSK icon
183
GSK
GSK
$106B
$1.44M 0.09%
26,042
+2,171
+9% +$113K
CBRE icon
184
CBRE Group
CBRE
$42.9B
$1.44M 0.09%
13,224
-12,125
-48% -$1.24M
CAJ
185
DELISTED
Canon, Inc.
CAJ
$1.42M 0.09%
58,160
+29,127
+100% +$685K
ONEW icon
186
OneWater Marine
ONEW
$201M
$1.41M 0.09%
23,100
+600
+3% +$29.3K
TTMI icon
187
TTM Technologies
TTMI
$14.5B
$1.41M 0.09%
94,400
+77,200
+449% +$1.08M
BMO icon
188
Bank of Montreal
BMO
$127B
$1.37M 0.09%
12,719
+889
+8% +$95.8K
CRM icon
189
Salesforce
CRM
$158B
$1.37M 0.09%
5,383
+291
+6% +$81.8K
LIN icon
190
Linde
LIN
$226B
$1.36M 0.09%
3,932
+628
+19% +$203K
ORGO icon
191
Organogenesis Holdings
ORGO
$239M
$1.36M 0.09%
147,200
+91,900
+166% +$976K
AMN icon
192
AMN Healthcare
AMN
$1.4B
$1.35M 0.09%
+11,000
New +$1.22M
FTS icon
193
Fortis
FTS
$28.7B
$1.34M 0.09%
27,795
+1,879
+7% +$85.1K
HVT icon
194
Haverty Furniture Companies
HVT
$454M
$1.33M 0.09%
43,400
-6,500
-13% -$210K
AVAH icon
195
Aveanna Healthcare
AVAH
$2.07B
$1.31M 0.08%
177,400
+7,200
+4% +$52.3K
WMK icon
196
Weis Markets
WMK
$1.86B
$1.28M 0.08%
19,500
+4,500
+30% +$273K
JAMF
197
DELISTED
Jamf
JAMF
$1.23M 0.08%
32,400
+6,200
+24% +$240K
HSTM icon
198
HealthStream
HSTM
$840M
$1.21M 0.08%
45,700
+1,100
+2% +$29.1K
VGSH icon
199
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$1.2M 0.08%
19,715
– –
CORT icon
200
Corcept Therapeutics
CORT
$12B
$1.18M 0.08%
+59,682
New +$1.21M
6 7
8
9 10

Similar funds

SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return

Summit Global Investments's Q4 2021 Portfolio in Review

As of Q4 2021, Summit Global Investments held 660 positions worth $1.56B, up 17% from $1.33B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Summit Global Investments deployed $107M of net new capital in Q4 2021, opening 197 new positions and adding to 199 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 95,044 shares worth $20.9M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Intuit, an estimated $11.9M trimmed.

  • Summit Global Investments's largest Q4 2021 buy was Vertex Pharmaceuticals: 95,044 shares worth $20.9M.
  • Summit Global Investments added most to Bristol-Myers Squibb in Q4 2021, an estimated $17.9M increase.
  • Summit Global Investments's biggest Q4 2021 reduction was Intuit, cutting an estimated $11.9M.
  • Summit Global Investments fully exited Regeneron Pharmaceuticals in Q4 2021, selling an estimated $11.4M.
  • Summit Global Investments's ten largest holdings make up 24% of its $1.56B portfolio in Q4 2021.
  • Summit Global Investments opened 197 new positions and closed 124 in Q4 2021.
  • Summit Global Investments's portfolio value rose 17% quarter-over-quarter to $1.56B.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.